These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25454006)

  • 1. Chemoprevention and screening for lung cancer: changing our focus to former smokers.
    Clamon G
    Clin Lung Cancer; 2015 Jan; 16(1):1-5. PubMed ID: 25454006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer chemoprevention: an integrated approach.
    Lippman SM; Spitz MR
    J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The finding of premalignant lesions is not associated with smoking cessation in chemoprevention study volunteers.
    Schook RM; Postmus BB; van den Berg RM; Sutedja TG; Man de FS; Smit EF; Postmus PE
    J Thorac Oncol; 2010 Aug; 5(8):1240-5. PubMed ID: 20581710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of lung cancer: the rise and demise of beta-carotene.
    Omenn GS
    Annu Rev Public Health; 1998; 19():73-99. PubMed ID: 9611613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
    Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
    Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention.
    Burns DM
    Cancer; 2000 Dec; 89(11 Suppl):2506-9. PubMed ID: 11147637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worldwide overview of the current status of lung cancer diagnosis and treatment.
    Bunn PA
    Arch Pathol Lab Med; 2012 Dec; 136(12):1478-81. PubMed ID: 23194039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers.
    Keith RL; Blatchford PJ; Merrick DT; Bunn PA; Bagwell B; Dwyer-Nield LD; Jackson MK; Geraci MW; Miller YE
    Cancer Prev Res (Phila); 2019 Oct; 12(10):721-730. PubMed ID: 31308004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.
    Tanvetyanon T; Bepler G
    Cancer; 2008 Jul; 113(1):150-7. PubMed ID: 18429004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of retinoid chemoprevention of lung cancer.
    Benner SE; Lippman SM; Hong WK
    Oncology (Williston Park); 1995 Mar; 9(3):205-10; discussion 210, 213-4, 216. PubMed ID: 7669514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to lung cancer prevention.
    McWilliams A; Lam S
    Curr Oncol Rep; 2002 Nov; 4(6):487-94. PubMed ID: 12354360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity in relation to all-site and lung cancer incidence and mortality in current and former smokers.
    Alfano CM; Klesges RC; Murray DM; Bowen DJ; McTiernan A; Vander Weg MW; Robinson LA; Cartmel B; Thornquist MD; Barnett M; Goodman GE; Omenn GS
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2233-41. PubMed ID: 15598785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
    Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer screening as a teachable moment for smoking cessation.
    Taylor KL; Cox LS; Zincke N; Mehta L; McGuire C; Gelmann E
    Lung Cancer; 2007 Apr; 56(1):125-34. PubMed ID: 17196298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer prevention: the guidelines.
    Dragnev KH; Stover D; Dmitrovsky E;
    Chest; 2003 Jan; 123(1 Suppl):60S-71S. PubMed ID: 12527565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reexamining Rates of Decline in Lung Cancer Risk after Smoking Cessation. A Meta-analysis.
    Reitsma M; Kendrick P; Anderson J; Arian N; Feldman R; Gakidou E; Gupta V
    Ann Am Thorac Soc; 2020 Sep; 17(9):1126-1132. PubMed ID: 32603182
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial.
    van der Aalst CM; van den Bergh KA; Willemsen MC; de Koning HJ; van Klaveren RJ
    Thorax; 2010 Jul; 65(7):600-5. PubMed ID: 20627916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodical multiphasic screening and lung cancer prevention.
    Carel RS
    Methods Inf Med; 1998 Jun; 37(2):182-7. PubMed ID: 9656662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should lung cancer screening with low-dose computed tomography be routine for smokers and former smokers? The evidence is insufficient to support routine low-dose CT in these patients.
    Brown SR
    Clin Adv Hematol Oncol; 2014 Oct; 12(10):701, 704-6. PubMed ID: 25658898
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.